Dihydroergocristine Mesilate

甲磺酸双氢麦角汀

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDihydroergocristine Mesilate
Drug Alias NameNehydrin
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha adrenergic receptor antagonists
TargetsAlpha adrenergic receptor
Therapy Area/IndicationsMental DisordersHypertensionVascular Diseases +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSanochemia Pharmazeutika GmbH
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMental DisordersHypertensionVascular Diseases +[5
Inactive IndicationsN/A

Other Information

ATC CodeC04AE04